Chemoinformaics analysis of GAMMA-HYDROXYGLUTAMIC ACID
| Molecular Weight | 163.129 | nRot | 4 |
| Heavy Atom Molecular Weight | 154.057 | nRig | 2 |
| Exact Molecular Weight | 163.048 | nRing | 0 |
| Solubility: LogS | -0.151 | nHRing | 0 |
| Solubility: LogP | -2.588 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 19.4611 |
| nHD | 4 | BPOL | 10.1949 |
| QED | 0.272 |
| Synth | 3.483 |
| Natural Product Likeliness | 0.765 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.049 |
| HIA | 0.831 |
| CACO-2 | -6.241 |
| MDCK | 0.00803603 |
| BBB | 0.524 |
| PPB | 0.1525 |
| VDSS | 0.419 |
| FU | 0.83533 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.03 |
| CYP2c19-inh | 0.033 |
| CYP2c19-sub | 0.05 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.126 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.162 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.026 |
| CL | 2.51 |
| T12 | 0.852 |
| hERG | 0.034 |
| Ames | 0.027 |
| ROA | 0.004 |
| SkinSen | 0.205 |
| Carcinogencity | 0.017 |
| EI | 0.07 |
| Respiratory | 0.273 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.882 |